Table 3.
Proportion of prescriptions in each category accounted for by the newly approved medications, 2011
| Primary care provider typea | Total number of prescriptions, N (% of all prescriptions in medication class) |
|---|---|
| Dabigatran | |
| Nurse practitioner (N = 383) | 280 (2.8) |
| Physician assistant (N = 451) | 374 (3.2) |
| Primary care physician (N = 4148) | 13,261 (4.9) |
| Aliskiren | |
| Nurse practitioner (N = 469) | 478 (0.5) |
| Physician assistant (N = 548) | 707 (0.6) |
| Primary care physician (N = 4338) | 16,793 (0.8) |
| Sitagliptin/saxagliptin | |
| Nurse practitioner (N = 435) | 6126 (11.7) |
| Physician assistant (N = 527) | 7895 (12.7) |
| Primary care physician (N = 4312) | 153,926 (13.0) |
| Pitavastatin | |
| Nurse practitioner (N = 451) | 145 (0.2) |
| Physician assistant (N = 526) | 299 (0.4) |
| Primary care physician (N = 4299) | 6367 (0.5) |
aN indicates the total number of each provider type regularly prescribing each medication class